The efficacy of the combination of sertraline with buspirone for smoking cessation: A randomized clinical trial in nondepressed smokers

European Archives of Psychiatry and Clinical Neuroscience

Volumn 257, Issue 7, 2007, Pages 383-388

  Carrão, Jorge Luiz ^a   Moreira, Leila Beltrami ^b   Fuchs, Flávio Danni ^c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antidepressant; Anxiolytic; Buspirone; Sertraline; Smoking cessation

Indexed keywords

BUSPIRONE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGED; BUSPIRONE; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 42949124914     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-007-0726-2     Document Type: Article

References (37)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). Washington, DC
2. Byerley WF, McConnell EJ, McCabe RT, Dawson TM, Grosser BI, Wamsley JK (1987) Chronic administration of sertraline, a selective serotonin uptake inhibitor, decreased the density of Badrenergic receptors in rat frontoparietal cortex. Brain Res 421:377-381
3. Cerveri I, Accordini S, Verlato G, Corsico A, Burney P, de Marco R, for the European Community Respiratory Health Survey (ECRHS) Study Group (2001) Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J 18:85-92
4. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ, Vanvunakis H (1995) A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. J Clin Psychopharmacol 15:182-191
5. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587-599
6. Coccaro EF, Silverman JM, Klar HM, Horvath TB, Siever LJ (1994) Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry 51:318-324
7. Covey LS, Glassman AH, Stetner F (2002) A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 159:1731-1737
8. Doogan DP, Caillard VJ (1988) Sertraline: a new antidepressant. J Clin Psychiatry 49(suppl):46-51
9. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decrease in brain reward function during nicotine withdrawal. Nature 393:767-769
10. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Assessment Collaborating Group (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347-1360
11. Fishbein DH, Lozovsky D, Jaffe JH (1989) Impulsivity, agression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 25:1049-1066
12. Garcia-Colunga J, Awad IN, Miledi R (1997) Blockage of muscle and neuronal nicotinic acetylcoline receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 94:2041-2044
13. Gelenberg AJ (1994) Buspirone: seven-year update. J Clin Psychiatry 55:222-229
14. Glassman AH, Stetner F, Walsh BT (1988) Heavy smokers, smoking cessation, and clonidine: results of a double-blind randomized trial. JAMA 259:2863-2866
15. Heatherton TF, Kozlowski LT, Frecker RC (1991) The Fagerström Test for Nicotine ependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 86:1119-1127
16. Hilleman DE, Mohiuddin SM, Delcore MG (1994) Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation. J Clin Pharmacol 34:222-224
17. Hughes JR, Stead LF, Lancaster T (2006) Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update software
18. Hughes JR, Stead LF, Lancaster T (2006) Anxiolytics for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update software
19. Jamner LD, Shapiro D, Jarvik ME (1999) Nicotine reduces the frequency of anger reports in smokers and nonsmorkers with high but not low hostility: an ambulatory study. Exp Clin Psychopharmacol 7:454-463
20. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685-691
21. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR, for varenicline Phase 3 Study Group (2006) JAMA 296:56-63
22. Koe BK (1990) Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J Clin Psychiatry 51B:13-17
23. Levin ED, Briggs SJ, Christopher NC (1993) Sertraline attenuates hyperphagia in rats following nicotine withdrawal. Pharmacol Biochem Behav 44:51-61
24. Li X, Rainnie DG, McCarley RW, Greene RW (1998) Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci 18:1904-1912
25. Manfredi C, Crittenden KS, Warnecke R, Engler J, Cho YI, Shaligram C (1999) Evaluation of a motivational smoking cessation intervention for women in public health clinics. Prev Med 28:51-60
26. Marques ACPR, Campana A, Gigliotti AP (2001) Consensus on the treatment of nicotine dependence. Rev Bras Psiquiatr 23:200-214
27. Marshall L, Schooley M, Ryan H, Cox P, Easton A, Healton C, Jackson K, Dvis KC, Homsi G, Centers for Disease Control, Prevention (2006) Youth tobacco surveillance - United States, 2001-2002. MMWR Surveill Summ 55(3):1-56
28. Masur J, Monteiro MG (1983) Validation of the CAGE alcoholism screening test in Brazilian psychiatric hospital setting. Braz J Med Biol Res 16:215-218
29. Moreira LB, Fuchs FD, Moraes RS, Bredemeier M, Cardoso S (1995) Prevalence of smoking and associated factors in a metropolitan area of southern Brazil. Rev Saúde Pública 29:46-51
30. Nuesch R, Schroeder K, Dieterle T (2001) Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. Br Med J 323:142-146
31. Prochazka AV (2000) New developments in smoking cessation. Chest 117:169S-175S
32. Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D (1998) A randomized trial of nortriptyline for smoking cessation. Arch Int Med 158:2035-2039
33. Sanders-Bush E, Breeding M, Knoth K, Tsutsumi M (1989) Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology 99:64-69
34. Schweizer E, Rickels K (1997) Strategies for treatment of generalized anxiety in the primary care setting. J Clin Psychiatry 58:27-31
35. Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berlin) 148:33-40
36. Ursin R (2002) Physiological review-Serotonin and sleep. Sleep Med Rev 6:57-69
37. Wetter DW, Carmack CL, Anderson CB (2000) Tobacco withdrawal signs and symptoms among women with and without a history of depression. Exp Clin Psychopharmacol 8:88-96